An international study opens the door to personalized treatment for heart failure

(Universidad de Navarra) An international study has identified a molecule that will open the door to personalized treatment for heart failure (HF). The results have been published in the latest issue of Nature Communications. The article shows that an excess of lysyl oxidase-like 2 produces fibrosis of the cardiac muscle, which impedes its normal functioning and stimulates the development of HF. The experimental studies confirm that the elimination of this excess repairs the fibrosis and alleviates the heart function.
Source: EurekAlert! - Social and Behavioral Science - Category: Global & Universal Source Type: news